Agios Pharmaceuticals | Eiendeler


Assets Endring
Acceleron Pharma XLRN:US $ 479M 15M
Alexion Pharmaceuticals ALXN:US $ 16703.2M 1445.3M
Alnylam Pharmaceuticals ALNY:US $ 3307.28M 67.08M
Amgen AMGN:US $ 65011M 3342M
AstraZeneca AZN:LN 64112M 4183M
Bayer BAYN:GR € 123667M 1807M
Biogen BIIB:US $ 24934.1M 577.7M
Biomarin Pharmaceutical BMRN:US $ 5302.11M 579.27M
Bluebird Bio BLUE:US $ 2107.79M 578.69M
Bristol Myers Squibb BMY:US $ 128076M 1209M
Daiichi Sankyo 4568:JP Y 2063186M 42433M
Eli Lilly And LLY:US $ 41967M 864.2M
Exelixis EXEL:US $ 2046M 91M
Gilead Sciences GILD:US $ 55934M 3807M
GlaxoSmithKline GSK:LN 84640M 258M
Immunogen IMGN:US $ 247.95M 21.78M
IONIS PHARMACEUT IONS:US $ 3078M 12M
JAZZ PHA JAZZ:US $ 6291.96M 225.46M
Merk MRK:US $ 90615M 5702M
Novartis NVS:US $ 129678M 5915M
Pfizer PFE:US $ 177934M 11598M
Puma Biotechnology PBYI:US $ 263M 38M
Regeneron Pharmaceuticals REGN:US $ 14428.7M 1328.8M
Sarepta Therapeutics SRPT:US $ 2883M 64M
Seattle Genetics SGEN:US $ 3004.96M 840.4M
Vertex Pharmaceuticals VRTX:US $ 10216.37M 1323.17M
YTE INCY:US $ 3212.32M 459.9M



Agios Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jan 2021.